Completed

Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. Analysis of Risk Factors and Impact on the Outcome.

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Procedure Data

Collected from past medical records and data - Retrospective
Procedure
Who is being recruted

Infections+3

+ Pneumonia

+ Respiratory Tract Diseases

Over 16 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.
Observational
Study Start: October 2012
See protocol details

Summary

Principal SponsorUniversity of Zurich
Last updated: May 28, 2014
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2012

Actual date on which the first participant was enrolled.

In this retrospective cohort study, we plan to include all patients presenting with a community-acquired pneumococcal pneumonia at the University Hospital of Zurich between January 1, 2006 and June 30, 2012 (6½ years). The patients will be identified either with one or more blood culture pairs positive for S. pneumoniae or with a positive pneumococcal urine antigen assay in combination with the clinical diagnosis of CAP, which was based on the presence of select clinical features (e.g., cough, fever, sputum production, and pleuritic chest pain) and is supported by imaging of the lung, usually by chest radiography according to Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of CAP in adults [11]. CAP is not considered if the patient is discharged from a hospital less than 7 days before the current hospital admission, if the first blood culture or urinary antigen assay is obtained more than 1 week after hospital admission, or if the patient has no clinical diagnosis of CAP at the time of admission. Patients referred from or transferred to another hospital are excluded. After identification of eligible patients upon microbiological results, medical records are reviewed using a standardized data collection questionnaire. Comorbidity is determined using the Charlson comorbidity index [10]. Additionally, all patients are classified according to the multimorbidity patterns proposed by Holden et al. [12]. These are: arthritis, osteoporosis, other chronic pain, bladder problems, and irritable bowel; asthma, chronic obstructive pulmonary disease, and allergies; back/neck pain, migraine, other chronic pain, and arthritis; high blood pressure, high cholesterol, obesity, diabetes, and fatigue; cardiovascular disease, diabetes, fatigue, high blood pressure, high cholesterol, and arthritis; and irritable bowel, ulcer, heartburn, and other chronic pain. Time calculation is based upon the moment of emergency room (ER) admission.

Principal SponsorUniversity of Zurich
Last updated: May 28, 2014
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

122 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 16 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

InfectionsPneumoniaRespiratory Tract DiseasesRespiratory Tract InfectionsCommunity-Acquired InfectionsCommunity-Acquired Pneumonia

Criteria

4 inclusion criteria required to participate
detection of Streptococcus pneumoniae in blood cultures, tracheal secretion or sputum OR/AND

positive urinary pneumococcal antigen AND

presence of cough and presence of one of the following signs/symptoms: new focal chest signs; dyspnoea; tachypnoea; fever AND

radiologic signs of pneumonia

2 exclusion criteria prevent from participating
Hospital-acquired or ventilator-associated pneumonia

Patients referred from or transferred to another hospital

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

University Hospital Zurich, Division of Internal Medicine

Zurich, SwitzerlandOpen University Hospital Zurich, Division of Internal Medicine in Google Maps
CompletedOne Study Center